• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

焦磷酸钙沉积病(CPPD)的治疗选择。

Calcium pyrophosphate deposition (CPPD) disease - Treatment options.

机构信息

Mater Misericordiae University Hospital, Eccles St, Dublin 7, Ireland; University College Dublin, Ireland.

出版信息

Best Pract Res Clin Rheumatol. 2021 Dec;35(4):101720. doi: 10.1016/j.berh.2021.101720. Epub 2021 Oct 28.

DOI:10.1016/j.berh.2021.101720
PMID:34756508
Abstract

In contrast to gout, no disease-modifying therapies currently exist that reduce articular crystal deposition of calcium pyrophosphate crystals (CPPs). Treatment is aimed at ameliorating the inflammatory response and reducing the frequency and severity of clinical symptoms due to CPP deposition (CPPD). Despite being one of the most common forms of inflammatory arthritis, CPPD remains under-studied and evidence-based treatment guidelines remain lacking. Commonly used treatments for clinical manifestations of CPPD (non-steroidal anti-inflammatory drugs [NSAIDs], colchicine and corticosteroids [CSs]) are extrapolated from use in gout. Anakinra and tocilizumab can be used in refractory cases. Though no current crystal-targeted treatments exist, studies suggest that nucleoside analogues and phosphocitrate can attenuate calcification of human cartilage ex-vivo. Hindering research, is the lack of a well-defined description of CPPD. However, international working groups have convened to establish classification criteria and validated outcome domains for CPPD. This should help facilitate the setting up of large multicentre studies, with well-defined cohorts, which can evaluate suitable therapies, providing high levels of evidence to guide clinicians. Here, we summarise and discuss the currently available anti-inflammatory treatment options for CPPD and discuss potential future crystal-targeted approaches.

摘要

与痛风相反,目前尚无能够减少焦磷酸钙晶体(CPP)关节结晶沉积的疾病修正治疗方法。治疗的目的是改善炎症反应,减少由于 CPP 沉积(CPPD)引起的临床症状的频率和严重程度。尽管 CPPD 是最常见的炎症性关节炎形式之一,但对其研究仍不足,缺乏基于证据的治疗指南。常用于 CPPD 临床表现的治疗方法(非甾体抗炎药 [NSAIDs]、秋水仙碱和皮质类固醇 [CSs])是从痛风治疗中推断出来的。对于难治性病例,可以使用阿那白滞素和托珠单抗。虽然目前尚无针对晶体的治疗方法,但研究表明,核苷类似物和膦酸盐可以体外抑制人软骨的钙化。由于缺乏对 CPPD 的明确描述,阻碍了研究的开展。然而,国际工作组已经召集起来,为 CPPD 建立分类标准和验证的结局领域。这应该有助于建立具有明确队列的大型多中心研究,评估合适的治疗方法,提供高水平的证据来指导临床医生。在这里,我们总结和讨论了目前 CPPD 的抗炎治疗选择,并讨论了潜在的未来针对晶体的方法。

相似文献

1
Calcium pyrophosphate deposition (CPPD) disease - Treatment options.焦磷酸钙沉积病(CPPD)的治疗选择。
Best Pract Res Clin Rheumatol. 2021 Dec;35(4):101720. doi: 10.1016/j.berh.2021.101720. Epub 2021 Oct 28.
2
Management of calcium pyrophosphate crystal deposition disease: A systematic review.焦磷酸钙晶体沉积病的管理:一项系统评价。
Semin Arthritis Rheum. 2021 Feb;51(1):84-94. doi: 10.1016/j.semarthrit.2020.10.005. Epub 2020 Dec 21.
3
Recent advances in the therapeutic management of calcium pyrophosphate deposition disease.焦磷酸钙沉积病治疗管理的最新进展
Front Med (Lausanne). 2024 Mar 11;11:1327715. doi: 10.3389/fmed.2024.1327715. eCollection 2024.
4
Therapy for CPPD: Options and Evidence.CPPD 治疗:选择和证据。
Curr Rheumatol Rep. 2018 Apr 19;20(6):31. doi: 10.1007/s11926-018-0739-z.
5
Diagnosis and Treatment of Calcium Pyrophosphate Deposition (CPPD) Disease: A Review.焦磷酸钙沉积(CPPD)病的诊断与治疗:综述
Open Access Rheumatol. 2023 Mar 22;15:33-41. doi: 10.2147/OARRR.S389664. eCollection 2023.
6
Update on calcium pyrophosphate deposition.焦磷酸钙沉积病的最新进展
Clin Exp Rheumatol. 2016 Jul-Aug;34(4 Suppl 98):32-8. Epub 2016 Jul 22.
7
Patient-Reported Outcomes in Calcium Pyrophosphate Deposition Disease Compared to Gout and Osteoarthritis.焦磷酸钙沉积病与痛风和骨关节炎的患者报告结局比较。
J Rheumatol. 2023 Aug;50(8):1058-1062. doi: 10.3899/jrheum.2023-0031. Epub 2023 Apr 15.
8
Review: Unmet Needs and the Path Forward in Joint Disease Associated With Calcium Pyrophosphate Crystal Deposition.综述:焦磷酸钙晶体沉积相关关节疾病的未满足需求和前进道路。
Arthritis Rheumatol. 2018 Aug;70(8):1182-1191. doi: 10.1002/art.40517. Epub 2018 Jun 14.
9
Pathogenesis of calcium pyrophosphate deposition disease.焦磷酸钙沉积病的发病机制。
Best Pract Res Clin Rheumatol. 2021 Dec;35(4):101718. doi: 10.1016/j.berh.2021.101718. Epub 2021 Oct 22.
10
The role of Interleukin-1 receptor antagonist as a treatment option in calcium pyrophosphate crystal deposition disease.白细胞介素-1 受体拮抗剂在焦磷酸钙晶体沉积病治疗中的作用。
Mol Biol Rep. 2021 May;48(5):4789-4796. doi: 10.1007/s11033-021-06457-z. Epub 2021 Jun 1.

引用本文的文献

1
A Patient Presenting with Joint Deformities and ST-Elevation Myocardial Infarction.一名出现关节畸形和ST段抬高型心肌梗死的患者。
Diagnostics (Basel). 2025 Sep 5;15(17):2254. doi: 10.3390/diagnostics15172254.
2
Steroid or pseudogout? Analysis of white deposits in tissues during surgery.类固醇性关节炎还是假性痛风?手术中组织白色沉积物的分析。
Arch Orthop Trauma Surg. 2025 Jun 16;145(1):345. doi: 10.1007/s00402-025-05945-2.
3
Ectopic calcifications in the musculoskeletal field: the basis for preventive and curative pharmacological strategies.
肌肉骨骼系统的异位钙化:预防和治疗性药物策略的基础
Clin Rheumatol. 2025 Mar;44(3):869-886. doi: 10.1007/s10067-025-07335-w. Epub 2025 Jan 24.
4
Inhibition of Pyroptosis by Hydroxychloroquine as a Neuroprotective Strategy in Ischemic Stroke.羟氯喹抑制细胞焦亡作为缺血性脑卒中的神经保护策略
eNeuro. 2024 Dec 18;12(1). doi: 10.1523/ENEURO.0254-24.2024.
5
Efficacy of a single ultrasound-guided injection of high molecular weight hyaluronic acid combined with collagen tripeptide in patients with knee osteoarthritis and chondrocalcinosis.单次超声引导下注射高分子量透明质酸联合胶原三肽治疗膝骨关节炎合并软骨钙质沉着症的疗效
Front Med (Lausanne). 2024 Jul 19;11:1437160. doi: 10.3389/fmed.2024.1437160. eCollection 2024.
6
Recent advances in the therapeutic management of calcium pyrophosphate deposition disease.焦磷酸钙沉积病治疗管理的最新进展
Front Med (Lausanne). 2024 Mar 11;11:1327715. doi: 10.3389/fmed.2024.1327715. eCollection 2024.
7
An Update on the Diagnosis and Management of Calcium Crystal Disease.钙结晶病的诊断与治疗进展。
Curr Rheumatol Rep. 2023 Aug;25(8):145-151. doi: 10.1007/s11926-023-01106-9. Epub 2023 May 30.
8
Management of temporomandibular joint diseases: a rare case report of coexisting calcium pyrophosphate crystal deposition and synovial chondromatosis.颞下颌关节疾病的治疗:共存焦磷酸钙晶体沉积和滑膜软骨瘤病的罕见病例报告。
BMC Oral Health. 2022 Dec 31;22(1):662. doi: 10.1186/s12903-022-02695-0.